외과용 스테이플러 시장 규모, 점유율, 동향 및 예측 : 종류, 제품 유형, 기구, 용도, 최종사용자, 지역별(2026-2034년)

The global surgical stapler market size was valued at USD 5.10 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 9.04 Billion by 2034, exhibiting a CAGR of 6.02% from 2026-2034. North America currently dominates the market, holding a market share of 38.2% in 2025. The region benefits from an advanced healthcare infrastructure, high surgical procedure volumes driven by chronic disease burden, widespread adoption of powered and robotic-assisted staplers, and the presence of leading medical device manufacturers that continuously introduce innovative stapling solutions, collectively contributing to the region's surgical stapler market share.

The global surgical stapler market is experiencing growth driven by the rising shift toward minimally invasive surgical procedures across multiple specialties, including gastrointestinal, bariatric, thoracic, and colorectal surgery, which requires advanced stapling devices capable of operating within confined anatomical spaces. The growing global burden of chronic diseases, such as obesity, cardiovascular conditions, and colorectal cancer, is generating greater volumes of complex surgeries requiring reliable tissue closure mechanisms. Technological advancements in powered and robotic-compatible staplers, including the integration of real-time tissue-sensing feedback and adaptive compression algorithms, are transforming stapling from a mechanical closure task to a data-driven clinical process. Additionally, expanding healthcare infrastructure in emerging economies, increasing healthcare expenditure, and favorable reimbursement frameworks across major markets further support broad adoption of surgical staplers as standard-of-care instruments in modern operating rooms.

The United States is emerging as a significant region in the surgical stapler market due to the increasing number of surgical procedures performed across the country. This rise is supported by an aging population, high obesity rates, and the growing prevalence of gastrointestinal and cardiovascular disorders that frequently require surgical intervention. As healthcare providers handle a larger surgical workload, the demand for reliable devices that support efficient tissue closure and improve procedural outcomes continues to expand. Reflecting this trend, in 2024, Ethicon, a Johnson & Johnson MedTech company, launched the ECHELON LINEAR(TM) Cutter in the United States. The surgical stapler integrated 3D-Stapling Technology and Gripping Surface Technology to enhance staple line stability during procedures and improve control during tissue transection. The introduction of advanced stapling technologies is supporting surgical efficiency and strengthening the adoption of modern wound closure devices across healthcare facilities.

SURGICAL STAPLER MARKET TRENDS:

Growing Geriatric Population Requiring Surgical Care

The expanding global elderly population is a major factor increasing the demand for surgical procedures, which subsequently supports the adoption of surgical staplers across healthcare systems. Older adults are more susceptible to conditions, such as cardiovascular diseases, gastrointestinal disorders, and orthopedic complications, that frequently require operative treatment. Surgical staplers play an important role in these procedures by providing reliable tissue closure, reducing surgical time, and supporting effective healing in patients with complex health conditions. Demographic projections further highlight the scale of this trend. According to the World Health Organization (WHO), by 2030 around one in six people globally will be aged 60 years or older, with the population in this age group increasing from 1 billion in 2020 to approximately 1.4 billion. The global population aged 60 years and above is expected to reach 2.1 billion by 2050, while the number of individuals aged 80 years or older is projected to rise to 426 million. These demographic changes are expected to increase surgical volumes and strengthen demand for efficient surgical instruments such as stapling devices.

Increasing Focus on Surgical Safety and Staple Line Reinforcement Technologies

The growing emphasis on improving surgical safety and reducing postoperative complications is driving innovation in staple line reinforcement technologies within the surgical stapler market. Surgeons are increasingly adopting devices that enhance the strength and reliability of staple lines, particularly in complex procedures involving delicate tissues or high internal pressure. Reinforcement materials help reduce complications, such as bleeding, leakage, and air leaks, that can occur following tissue transection and anastomosis. The use of bioabsorbable reinforcement components are gaining attention because they provide temporary structural support during the critical healing phase and gradually degrade as tissue recovery progresses. In 2024, Johnson & Johnson MedTech introduced the ECHELON ENDOPATH(TM) Staple Line Reinforcement device designed to strengthen staple lines in bariatric, thoracic, and general surgical procedures. The bioabsorbable reinforcement material was developed to improve staple line stability while reducing the risk of bleeding and air leaks during operations. The device also supported convenient loading and consistent coverage across the stapled tissue area, reflecting the broader industry trend of technologies that improve surgical reliability and patient outcomes.

Expansion of Robotic-Assisted Surgery Supporting Advanced Stapling Systems

The rapid growth of robotic-assisted surgical procedures is encouraging the development of specialized stapling technologies designed to integrate with robotic surgical platforms. Robotic systems allow surgeons to perform complex procedures with enhanced visualization, precision, and instrument control through minimally invasive approaches. As these technologies become more widely adopted in hospitals and surgical centers, there is an increase in the demand for stapling devices compatible with robotic platforms. Robotic staplers are designed to operate within confined anatomical spaces while providing surgeons with improved control over tissue compression and staple formation. In 2025, Intuitive received FDA clearance for the SP SureForm 45 surgical stapler developed for use with its da Vinci SP robotic surgery system. The device supported stapling during single-port minimally invasive procedures and incorporated tissue compression monitoring technology to help maintain secure stapling and reduce the risk of tissue damage. The integration of stapling systems with robotic surgical platforms highlights the growing role of advanced technologies in improving surgical precision and procedural outcomes.

SURGICAL STAPLER INDUSTRY SEGMENTATION:

Analysis by Type:

• Reusable
• Disposable

Disposable holds 71.2% of the market share, reflecting its widespread use across hospital operating rooms and ambulatory surgical centers. Its adoption is largely supported by the ability to eliminate sterilization-related risks and the operational costs associated with cleaning and reprocessing reusable instruments. This single-use device is supplied pre-sterilized and factory-calibrated, ensuring consistent mechanical performance from the first to the final firing cycle during surgical procedures. Such reliability is particularly important in complex gastrointestinal and bariatric surgeries where stable staple formation and dependable device performance are essential. Infection prevention policies in healthcare facilities are further encouraging the use of disposable devices, particularly in environments where minimizing cross-contamination risks is a priority. In addition, modern disposable stapler features lightweight structures and improved ergonomic designs, enabling better handling precision and enhanced surgeon comfort during extended surgical procedures. These developments are shaping evolving surgical staplers market trends by strengthening the preference for single-use surgical devices in modern healthcare settings.

Analysis by Product Type:

• Linear Surgical Stapler
• Circular Surgical Stapler
• Cutter Stapler
• Skin Stapler
• Stapler Reload
• Others

Circular surgical stapler leads the market with a share of 28.6%. Its widespread adoption is primarily attributed to its essential role in anastomosis procedures that require the secure connection of hollow organs during gastrointestinal, colorectal, esophageal, and bariatric surgeries. This device is designed to create uniform, circumferential staple lines that ensure reliable tissue approximation, particularly in anatomical areas that are difficult to access using linear or skin staplers. As a result, circular stapler is widely used in procedures including colorectal resection, low anterior resection, and sleeve gastrectomy. Its ability to deliver consistent staple formation helps improve surgical precision and supports effective healing following complex procedures. Continuous advancements in circular stapler design are also contributing to its adoption. Modern systems incorporate features, such as powered clamping mechanisms, adjustable staple heights, and improved ergonomic end effectors, which assist surgeons in achieving better control, reducing complications, and improving overall procedural outcomes. These advancements are expected to positively influence the surgical staplers market outlook by supporting the continued adoption of specialized stapling technologies in complex surgical procedures.

Analysis by Mechanism:

• Manual Surgical Staplers
• Powered Surgical Staplers

Manual surgical staplers dominate the market, with a share of 57.3%, because of their wide clinical applicability, affordability, and strong familiarity among surgeons across healthcare systems. These devices operate without the need for batteries or electronic components, making them dependable and easy to use in a variety of surgical environments. Their mechanical design allows surgeons to perform procedures with consistent control while reducing dependence on external power sources, which is particularly valuable in emergency surgeries and resource-limited medical facilities. Moreover, manual staplers are available in multiple configurations, including linear, circular, skin, and cutter variants, enabling their use across several surgical specialties. This versatility allows healthcare providers to perform a broad range of procedures without the need for specialized platforms or additional electronic accessories. The surgical staplers market forecast indicates continued adoption of manual staplers due to their reliability, cost efficiency, and adaptability across diverse surgical settings.

Analysis by Application:

• Abdominal and Pelvic Surgery
• General Surgery
• Cardiac and Thoracic Surgery
• Orthopedic Surgery
• Others

Abdominal and pelvic surgery represents the leading segment, with a market share of 32.5%. Abdominal and pelvic procedures encompass the broadest spectrum of stapler-dependent surgeries, including colorectal resections, gastrectomies, colostomy reversals, hysterectomies, and bariatric operations. The anatomical complexity and tissue diversity encountered in the abdominal and pelvic cavity demand staplers that offer precise articulation, reliable anastomosis formation, and consistent staple-line integrity across varying tissue thicknesses. For instance, bariatric surgery, one of the fastest-growing surgical specialties globally, relies on multiple sequential stapler firings per procedure in sleeve gastrectomy and gastric bypass operations, sustaining substantial device consumption per case. The rising prevalence of colorectal cancer, which ranks among the most frequently diagnosed malignancies worldwide, has further elevated surgical volumes in this application segment. According to the Global Cancer Observatory, colorectal cancer accounted for over 1.9 million new cases diagnosed globally in 2024, most of which require operative management involving precise tissue transection and anastomosis with surgical staplers.

Analysis by End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)

Hospitals and clinics represent the leading segment, with a market share of 81.4%. These healthcare facilities handle a large volume of surgical procedures across multiple specialties, making them the primary consumers of surgical stapling devices. Major tertiary care hospitals and academic medical centers regularly perform complex operations that require dependable tissue closure technologies, including gastrointestinal, bariatric, thoracic, cardiac, gynecologic, and oncologic surgeries. To support these procedures, hospitals maintain extensive inventories of surgical staplers, including manual, powered, and robotic-compatible systems. The continuous need for both reusable platforms and disposable stapling cartridges contributes to consistent procurement activity within hospital settings. Clinics and specialized surgical centers also contribute to device demand as they increasingly perform minimally invasive and day-care surgical procedures. This increasing procedural volume across healthcare facilities continues to support surgical staplers market growth.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America, accounting for 38.2% of the share, enjoys the leading position in the market. The region's dominance is underpinned by the highest concentration of advanced surgical facilities, the presence of leading global medical device manufacturers, and the rapid adoption of powered and robotic-compatible stapling technologies. Medicare's bundled payment programs and value-based care frameworks incentivize hospitals to minimize post-surgical complications, such as staple-line leaks, driving procurement of premium stapling systems with superior tissue adaptation. According to the American Hospital Association, in 2024, around 2.63 million surgical procedures were performed in the United States using da Vinci systems, representing a 17% increase compared to 2023, directly fueling demand for robotic-integrated stapler reloads and purpose-built cartridges. The growing shift of elective procedures from inpatient hospitals to ambulatory surgical centers further diversifies the end-user base, sustaining comprehensive demand for cost-effective and precision-engineered stapling solutions across the region.

KEY REGIONAL TAKEAWAYS:

UNITED STATES SURGICAL STAPLER MARKET ANALYSIS

The United States represents a vital market for surgical staplers because of its high surgical procedure volumes, well-established healthcare infrastructure, and rapid adoption of advanced medical technologies. Hospitals and surgical centers across the country perform a wide range of procedures that require reliable tissue closure devices, supporting sustained demand for surgical stapling systems. Healthcare providers in the United States also prioritize technologies that improve surgical precision, efficiency, and patient outcomes, encouraging manufacturers to introduce innovative stapling platforms in this market. Reflecting this trend, in 2024, Lexington Medical received FDA clearance and launched the AEON(TM) Powered Stapling System in the United States. The next-generation surgical stapling platform was developed to improve stapling precision, ergonomics, and overall clinical outcomes during surgical procedures. It also featured specialized reload options designed to enhance staple line quality and improve surgical workflow efficiency. The introduction of advanced powered stapling systems demonstrates the strong emphasis placed on technological innovation in the United States healthcare sector, which continues to support the widespread adoption of modern surgical staplers across hospitals and surgical facilities.

EUROPE SURGICAL STAPLER MARKET ANALYSIS

Europe represents a mature market for surgical staplers, attributed to well-established healthcare systems, high surgical procedure volumes, and a strong emphasis on improving clinical outcomes through standardized medical technologies. Hospitals and surgical centers across the region widely adopt advanced surgical devices to enhance procedural accuracy, reduce complications, and improve patient recovery. The region's healthcare policies also encourage the use of reliable and high-quality surgical instruments, which contributes to consistent demand for modern stapling systems. Demographic trends further strengthen this demand, particularly the growing elderly population that requires frequent surgical care. According to recent demographic estimates, the European Union population reached approximately 450.6 million people on 1 January 2025, with individuals aged 65 years and older accounting for more than one-fifth of the population, representing about 22.0%. The increasing proportion of older adults is associated with a higher prevalence of age-related health conditions that often require surgical treatment. This demographic shift is expected to sustain surgical procedure volumes across the region and support the continued adoption of surgical staplers in European healthcare facilities.

ASIA-PACIFIC SURGICAL STAPLER MARKET ANALYSIS

Asia-Pacific is emerging as the fastest-growing regional market for surgical staplers, driven by expanding healthcare infrastructure, increasing surgical procedure volumes, and a rising burden of chronic diseases that often require operative treatment. Governments and healthcare providers across the region are investing in modern medical technologies to improve surgical capacity and patient outcomes. The growing adoption of minimally invasive surgical techniques is also encouraging the use of advanced stapling devices that enable precise tissue closure in complex procedures. Reflecting this technological progress, in 2025, Genesis Medtech received regulatory approval in China for its iReach Omnia powered stapler featuring a 90° articulation capability. The device was designed to enhance surgical precision in laparoscopic procedures performed in confined anatomical spaces while improving maneuverability during operations. Such technological developments are strengthening surgical capabilities in the region and supporting the broader adoption of advanced surgical stapling systems across Asia-Pacific healthcare facilities.

LATIN AMERICA SURGICAL STAPLER MARKET ANALYSIS

Latin America represents a vital market for surgical staplers, supported by increasing surgical procedure volumes and the gradual adoption of advanced medical technologies across healthcare systems. Brazil and Mexico serve as the primary demand centers in the region owing to their large healthcare networks and the growing investment in modern surgical equipment. Hospitals are increasingly incorporating devices that support minimally invasive procedures and improve surgical efficiency. Reflecting this, in 2024, EziSurg Medical launched its easyEndo(TM) E-lite powered endoscopic staplers in Brazil after receiving regulatory approval from ANVISA. The launch marked the company's entry into South America's surgical device market and strengthened the availability of advanced stapling technologies in the region.

MIDDLE EAST AND AFRICA SURGICAL STAPLER MARKET ANALYSIS

The Middle East and Africa surgical stapler market is growing due to higher healthcare investments, increasing surgical procedure volumes, and the development of modern hospital infrastructure across several countries. Governments in the region are actively investing in healthcare facilities to improve medical services and support rising patient demand for surgical care. Demographic changes are also contributing to this growth. According to the Elderly Survey 2025, the population aged 60 years and over in Saudi Arabia reached approximately 1.7 million in 2025, representing about 4.8% of the total population. The gradual increase in the elderly population is associated with a higher prevalence of medical conditions that require surgical intervention, thereby supporting the demand for surgical stapling devices across hospitals and specialized treatment centers in the region.

COMPETITIVE LANDSCAPE:

Key players in the surgical stapler market are focusing heavily on technological innovation, product portfolio expansion, and global market penetration to strengthen their competitive positions. Companies are investing in research operations to introduce advanced stapling systems with improved precision, ergonomic design, and enhanced safety features that reduce complications during surgery. Many manufacturers are developing powered and automated staplers that improve consistency in staple formation and reduce manual force required during procedures. Integration of smart technologies, including sensors and feedback mechanisms that monitor tissue thickness and stapling performance, is also gaining traction. Firms are aligning their product development with the growing adoption of minimally invasive and robotic-assisted surgeries, which require more compact and specialized stapling devices. In addition, companies are expanding distribution networks, increasing accessibility in emerging markets, and strengthening regulatory compliance to meet rising demand from hospitals and ambulatory surgical centers.

The report provides a comprehensive analysis of the competitive landscape in the surgical stapler market with detailed profiles of all major companies, including:

• 3M Company
• B. Braun Melsungen AG
• CONMED Corporation
• Frankenman International Ltd
• Intuitive Surgical Inc.
• Johnson & Johnson
• Medtronic plc.
• Meril Life Sciences Pvt. Ltd.
• Purple Surgical International
• Smith & Nephew plc
• Welfare Medical Ltd.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the surgical stapler market?

2. What is the future outlook of the surgical stapler market?

3. What are the key factors driving the surgical stapler market?

4. Which region accounts for the largest surgical stapler market share?

5. Which are the leading companies in the global surgical stapler market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Surgical Stapler Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Reusable
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Disposable
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Product Type

• 7.1 Linear Surgical Stapler
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Circular Surgical Stapler
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Cutter Stapler
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Skin Stapler
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Stapler Reload
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by Mechanism

• 8.1 Manual Surgical Staplers
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Powered Surgical Staplers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Application

• 9.1 Abdominal and Pelvic Surgery
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 General Surgery
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Cardiac and Thoracic Surgery
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Orthopedic Surgery
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Others
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Market Breakup by End User

• 10.1 Hospitals and Clinics
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Ambulatory Surgical Centers (ASCs)
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia-Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 3M Company
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
    • 16.3.1.3 Financials
    • 16.3.1.4 SWOT Analysis
  • 16.3.2 B. Braun Melsungen AG
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
    • 16.3.2.3 SWOT Analysis
  • 16.3.3 CONMED Corporation
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
    • 16.3.3.3 Financials
    • 16.3.3.4 SWOT Analysis
  • 16.3.4 Frankenman International Ltd
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
  • 16.3.5 Intuitive Surgical Inc.
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
    • 16.3.5.3 Financials
    • 16.3.5.4 SWOT Analysis
  • 16.3.6 Johnson & Johnson
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
    • 16.3.6.3 Financials
    • 16.3.6.4 SWOT Analysis
  • 16.3.7 Medtronic plc.
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
    • 16.3.7.3 Financials
    • 16.3.7.4 SWOT Analysis
  • 16.3.8 Meril Life Sciences Pvt. Ltd.
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
  • 16.3.9 Purple Surgical International
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
  • 16.3.10 Smith & Nephew plc
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
    • 16.3.10.3 Financials
    • 16.3.10.4 SWOT Analysis
  • 16.3.11 Welfare Medical Ltd.
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio